Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 20;14(7):e27073.
doi: 10.7759/cureus.27073. eCollection 2022 Jul.

Propylthiouracil-Induced Skin Vasculitis

Affiliations
Case Reports

Propylthiouracil-Induced Skin Vasculitis

Mariana S Almeida et al. Cureus. .

Abstract

The use of propylthiouracil (PTU) is associated with the development of autoantibodies, namely, antineutrophil cytoplasmic antibodies (ANCAs), which are associated with the pathogenesis of ANCA-associated systemic vasculitis, most often related to the myeloperoxidase subtype (ANCA-MPO). The authors report the case of a 61-year-old woman on PTU for one year who was referred to Internal Medicine for a three-month evolution of painless non-blanching purple patches, non-pruriginous, involving the chest and legs. The autoimmunity revealed ANCA antibody positivity, with a cutaneous biopsy compatible with leukocytoclastic vasculitis/necrotizing vasculitis with involvement of small and medium-sized vessels. Clinical improvement was noted after the drug was discontinued, with the resolution of the analytical changes.

Keywords: adverse reactions; anca; antibodies; propylthiouracil; purpuric plaques; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Erythematous, non-pruritic, purpuric plaques.
Figure 2
Figure 2. Skin biopsy compatible with leukocytoclastic vasculitis/necrotizing vasculitis, a pattern that is entirely compatible with the clinical context of positive ANCA vasculitis.
ANCA: antineutrophil cytoplasmic antibody
Figure 3
Figure 3. Skin biopsy compatible with leukocytoclastic vasculitis.

References

    1. Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis. Trusau A, Brit ML. J Community Hosp Intern Med Perspect. 2018;8:35–37. - PMC - PubMed
    1. The safety and efficacy of antithyroid drugs. Azizi F. Expert Opin Drug Saf. 2006;5:107–116. - PubMed
    1. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Chen M, Gao Y, Guo XH, Zhao MH. Nat Rev Nephrol. 2012;8:476–483. - PubMed
    1. [Propylthiouracil-induced cutaneous vasculitis] Milanez FM, Gonçalves A. Costa LA, José FF, Enokihara MM, Silva de Souza AQ. Rev Bras Reumatol. 2008;48:55–58.
    1. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease. Aoki Y, Kitazawa K, Kobayashi H. Paediatr Int Child Health. 2019;39:142–145. - PubMed

Publication types

LinkOut - more resources